WO2023272388A1 - Système, procédé et dispositifs de manipulation de tissu à l'aide d'un transducteur ultrasonore à orientation électronique - Google Patents

Système, procédé et dispositifs de manipulation de tissu à l'aide d'un transducteur ultrasonore à orientation électronique Download PDF

Info

Publication number
WO2023272388A1
WO2023272388A1 PCT/CA2022/051038 CA2022051038W WO2023272388A1 WO 2023272388 A1 WO2023272388 A1 WO 2023272388A1 CA 2022051038 W CA2022051038 W CA 2022051038W WO 2023272388 A1 WO2023272388 A1 WO 2023272388A1
Authority
WO
WIPO (PCT)
Prior art keywords
ultrasound transducer
ultrasound
transducer device
interior chamber
alignment
Prior art date
Application number
PCT/CA2022/051038
Other languages
English (en)
Inventor
Nir KATCHINSKIY
Christopher CEROICI
Original Assignee
Pulsemedica Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2022/050582 external-priority patent/WO2023197057A1/fr
Application filed by Pulsemedica Corp. filed Critical Pulsemedica Corp.
Priority to CA3224096A priority Critical patent/CA3224096A1/fr
Publication of WO2023272388A1 publication Critical patent/WO2023272388A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00736—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
    • A61F9/00745—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments using mechanical vibrations, e.g. ultrasonic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N7/02—Localised ultrasound hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0086—Beam steering
    • A61N2007/0095—Beam steering by modifying an excitation signal

Definitions

  • the current application relates to electronically steerable ultrasonic transducers, and in particular to steerable ultrasonic transducers for cutting, ablating or manipulation of tissue.
  • HIFU high-intensity focused ultrasound
  • an ultrasound transducer device comprising: an alignment body defining an interior chamber, the alignment body configured to be physically coupled to a surface of a body portion to be treated; an ultrasound transducer array sized to be received within the interior chamber of the alignment body, the ultrasound transducer array comprising a plurality of individual ultrasound transducers; and an inlet port for injecting an acoustic coupling medium into the interior chamber between the ultrasound transducer array and the surface the portion of the body to be treated when the alignment body is physically coupled to the surface of the body portion to be treated.
  • the ultrasound transducer device further comprises: a sealing mechanism adapted to seal the ultrasound transducer device to a surface of a portion of a body to be treated when in use.
  • the sealing mechanism comprises a suction chamber surrounding at least a portion of the interior chamber.
  • the suction chamber is formed as part of the alignment body defining the interior chamber.
  • the suction chamber comprises a contacting ring surrounding the interior chamber that contacts the surface of the body portion and seals the alignment body to the surface when suction is applied to the suction chamber.
  • the sealing mechanism comprises an adhesive surface to which an adhesive can be applied and pressed against the portion of the body to be treated and seal the ultrasound transducer device to the surface of the portion of the body.
  • the ultrasound transducer device further comprises: an outlet port allowing a gas to be evacuated from the interior chamber.
  • the outlet port further allows a gas to enter the interior chamber.
  • the inlet port further allows the acoustic coupling medium to be extracted from the interior chamber.
  • the ultrasound transducer device further comprises: an extraction port allowing the acoustic coupling medium to be extracted from the interior chamber.
  • the plurality of individual ultrasound transducers are individually adjustable to allow the focusing of the ultrasound beam to electronically steered.
  • the plurality of individual ultrasound transducers of the ultrasound transducer array are arranged in a spherical shape.
  • the ultrasound transducer array comprises a portion providing an optical lens.
  • the transducer array comprises an optical path for coupling the optical lens to at least one of an optical imaging system and an optical treatment system.
  • the ultrasound transducer array comprises one or more registration marks allowing a positioning of the ultrasound transducer array to be determined.
  • the ultrasound transducer array is secured in a fixed position within the interior chamber.
  • the ultrasound transducer array is moveable within the interior chamber.
  • the ultrasound transducer device further comprises: one or more actuators for moving the transducer array within the interior chamber.
  • the one or more actuators comprise one or more piezo-electric actuators.
  • the one or more actuators are arranged to move the transducer array closer to or away from the surface the portion of the body to be treated.
  • an aperture of the ultrasound transducer array is sized approximately to a size of an eye.
  • an ultrasound treatment system comprising: an ultrasound transducer device according to any of the embodiments described above; and a computing device coupled to the ultrasound transducer array and configured to provide a driving signal to the ultrasound transducer array.
  • the ultrasound transducer system further comprises a vacuum pump connected to the suction chamber.
  • the driving signal to the ultrasound transducer array provides high-intensity focused ultrasound (HIFU) treatment.
  • HIFU high-intensity focused ultrasound
  • the ultrasound transducer system further comprises an optical coherent tomography (OCT) imaging system.
  • OCT optical coherent tomography
  • a method of performing an ultrasonic procedure comprising: affix an alignment housing to a patient at a treatment location; couple an ultrasonic transducer to the alignment housing; add an acoustic coupling media to the alignment housing between the ultrasonic transducer and the patient; and performing an ultrasonic procedure on the treatment location.
  • affixing the alignment housing comprises applying a suction to the treatment location through the alignment housing.
  • affixing the alignment housing comprises applying an adhesive to a portion of the alignment housing that will be in contact with the treatment location.
  • the ultrasonic transducer comprises an optical pathway for coupling to an optical imaging system, and the method further comprising: generating an image of at least a portion of the treatment location using the optical imaging system; identifying a target location in the image; and performing the ultrasonic procedure on the target location.
  • the method further comprises: generating an ultrasound image of at least an overlapping portion of the treatment location using ultrasound; and aligning the ultrasound transducer and the optical imaging system using the image and the ultrasound image.
  • FIG. 1 depicts ultrasonic treatment of an eye
  • FIG. 2 depicts pressure amplitudes during ultrasonic treatment of an eye
  • FIG. 3 depicts an ultrasound transducer device
  • FIG. 4 depicts a further ultrasound transducer device
  • FIG. 5 depicts an ultrasound treatment system
  • FIG. 6 depicts a further ultrasound transducer device suitable for internal use
  • FIG. 7 depicts components of an imaging system incorporating an ultrasonic transducer device
  • FIG. 8 depicts a method of performing a procedure using an ultrasonic device
  • FIG. 9 depicts a method of performing a procedure using an imaging system and an ultrasonic device.
  • An ultrasonic treatment device may have a transducer array within an alignment housing.
  • the alignment housing can be secured to a location being treated. Securing the alignment housing to the treatment location aligns the transducer array to the treatment location allowing for the precise targeting of the ultrasonic waves.
  • the device may also include one or more ports that can be used to inject, and or remove, an ultrasonic coupling medium into the device in order to fill a void between the surface the device is secured to and the transducer array.
  • FIG. 1 depicts ultrasonic treatment of an eye.
  • the figure shows a high intensity ultrasonic transducer array 101 , which may be a 2-dimensional transducer array, with an ultrasonic focus that is electronically controlled towards a particular treatment location 102 for the purpose of manipulating tissue at or within the target location, depicted as the crystalline lens 103.
  • the tissue manipulation may include for example an incision of the tissue, emulsification of tissue, bubble formation within the tissue, ionization of the tissue, removal of the tissue, vaporization of the tissue, softening or liquefaction of the tissue, as well as controlling or affecting the motion of tissue or components of tissues. These are only examples of possible tissue manipulations and other tissue manipulations may be performed.
  • the particular treatment location and size may be dependent upon the size of the ultrasonic transducer.
  • the figure depicts an example where precise incisions can be made inside the crystalline lens 103 of the eye, however the precise incision can target other treatment locations including in the vitreous humor, anterior chamber of the eye as well as other structures such as the cornea and lens capsule. Further, although depicted as being used for incisions or treatments of the eye, it is possible to apply a similar ultrasonic device for treatment of other locations including internal locations and external locations.
  • FIG. 2 depicts pressure amplitudes during ultrasonic treatment of an eye.
  • the figure shows an example of pressure amplitude that is generated by the system inside the crystalline lens 201 from two different angles 202a, 202b. It can be seen that the focal spot of the pressure wave, 203, is generated inside the lens to perform precise incision (emulsification, bubbles, ionization, removal, vaporization).
  • the ultrasonic transducer for other purposes, including for example ultrasound imaging, as well as possible tissue manipulation in addition to, or as an alternative to incisions.
  • the ultrasonic waves from the ultrasonic transducer may be used to control or affect the motion of tissue or components of tissues.
  • Focusing of the ultrasonic waves at a particular location in may require the ultrasonic transducer be held in a fixed position relative to the particular location. Securing the ultrasonic transducer to a location may be possible for certain locations on a patient or target. However for other locations, including for example a patient’s eye, securing the ultrasonic transducer in position can be difficult.
  • an alignment housing can be provided that can be secured to the patient to provide a mounting location for securing the ultrasonic transducer.
  • FIG. 3 depicts an ultrasound transducer device.
  • the figure depicts a device 300 for performing precise incisions inside a crystalline lens inside an eye.
  • the device comprises a transducer array 302 that can be coupled to an alignment housing 306.
  • An eye, with crystalline lens 303, is in contact with the device’s alignment housing 306.
  • the alignment is constructed such that an ultrasonic coupling medium can be injected into a volume that receives an ultrasonic transducer array.
  • the volume may be defined by a wall or walls that include one or more ports 304, 305.
  • the coupling medium may be injected through a port 305, while excess air/liquid can be expelled or removed through a second port 304.
  • the housing may have a surface that can be placed on the patient’s eye similar to a contact lens.
  • the surface may be a ring portion of a sphere or similar surface.
  • the contact surface of the housing may be secured to the patient’s eye by way of surface tension or possible with a vacuum or suction to secure the housing in place relative to the patient’s eye.
  • the housing provides an alignment body that defines an interior chamber adjacent to treatment area such as the eye.
  • a 2D array ultrasonic transducer, 301 that has electronically steerable focus point 302 can be received within a portion of the housing.
  • the housing aligns the transducer relative to the eye.
  • the ultrasonic coupling medium can be inserted into the space of the housing between the 2D array ultrasonic transducer and the eye. Although described as a 2D array, it is possible the ultrasonic transducer may have a 3D array.
  • FIG. 4 depicts a further ultrasound transducer device.
  • the figure depicts the device that is in contact with an eye, where the housing of the device 401 is touching the surface of the eye.
  • the device is similar to the device described above with regard to FIG. 3 and comprises a 2D electronically steerable ultrasound transducer 402.
  • the device of FIG. 4 further comprises one or more (two are depicted in FIG 4) actuators 403, which may be for example piezoelectric actuators, that can be used to position the transducer within the housing.
  • the actuators may move the transducer further or closer to the eye.
  • the actuators may be provided by various actuator devices including, for a piezoelectric actuator.
  • the coupling media may be added or removed through the ports.
  • the actuators 403 may be individually controlled in order to adjust the orientation of the transducer and possibly adjust the natural focus of the array.
  • the ultrasound transducer in FIG. 4 is depicted as having an optical window 404 for coupling an imaging system such as, but not limited to, Optical Coherence Tomography, Scanning Laser Ophthalmoscope, optical microscope. Further, although not depicted in the figure, it is possible to include one or more ultrasound sensors which may be used to perform ultrasonic imaging.
  • the device of FIG. 4 may have inlet, 405, and outlet, 406, ports for ultrasonic coupling medium, 407, that can be injected into the void between the eye and the transducer.
  • inlet, 405, and outlet, 406, ports for ultrasonic coupling medium, 407 that can be injected into the void between the eye and the transducer.
  • the fluid added/removed through the ports 405, 406 may be various different types of media that may have different properties or characteristics.
  • the fluid present between the transducer array 402 and the treatment location, depicted as the eye in FIG. 4 may be varied during the procedure.
  • the fluid present may be selected to have particularly desirable optical properties for the imaging system.
  • the fluid previously used for its optical properties may be removed and replaced with an ultrasound coupling media having properties that are desirable for the ultrasound procedure.
  • the fluid may be used for other purposes.
  • the flow may flow through the device during the procedure possibly to remove debris or contaminants from the treatment location, deliver medication or other compounds to the treatment location, etc.
  • the fluid may be heated or cooled in order to possibly heat/cool the treatment location as well as the ultrasound array.
  • the system’s housing can be constructed such that its perimeter can be connected or coupled securely to the surface of the eye.
  • the housing may have a perimeter that can contact the eye and be secured using suction that is generated by suction outlets 408, 409.
  • the perimeter may provide a suction or vacuum chamber that is open on the bottom where the perimeter contacts the patient’s eye.
  • the suction outlets 408,409 can create a vacuum or suction that secures the perimeter to the eye.
  • the vacuum chamber may have a deformable bottom surface that contacts the patient’s eye and deforms under suction to create a suction on the patient’s eye.
  • FIG. 5 depicts an ultrasound treatment system. This figure depicts an entire system for the device.
  • a personal computer (PC) or similar computing device may be provided to control the treatment system.
  • the PC 505 may communicate with one or more controllers.
  • a device controller 502 may control operation of the device.
  • the device controller may communicate with one or more motor controllers 503, that control the mechanical (e.g. piezoelectric) actuators for positioning the transducer.
  • the device controller may communicate with a transducer controller 504.
  • the transducer controller communicates with the transducer array, 501 through a series of delay lines 506 which may be used to steer the ultrasonic wave generated from the transducer array.
  • the controller may also communicate with a suction pump 507 and the acoustic matching pump 508.
  • the suction pump may apply suction to the alignment housing in order to secure the device to the patient’s eye, while the acoustic matching pump may control the acoustic matching fluid pumped into and/or out of the device from between the eye and the transducer.
  • the PC has means of controlling the system and display system parameters using a system control module 509 that consists of GUI 510.
  • the GUI provides access to one or more modules including for example a calibration module 511 , a planning module 512, and a treatment module 513.
  • the calibration module 511 can be used to calibrate one or more parameters of the system.
  • the planning module 512 may provide an interface for planning one or more treatment procedures using the system and the treatment module 513 may provide an interface for carrying out one or more treatment procedures using the system.
  • the above has described various devices and systems for treating an eye condition using ultrasound.
  • a similar device may be used for ultrasonic treatment as well as ultrasonic imaging or other tissue manipulation, of other portions of the body such as the skin, or possibly internally.
  • the alignment housing 514 may be affixed to the treatment location, for example using surface tension, suction, vacuum or other possible methods including possibly adhesives or mechanical means such as straps or tape.
  • the alignment housing may be removed from the patient after the treatment or procedure. Alternatively, the alignment housing may be left in place for subsequent treatment or procedures. Leaving the alignment housing in place may allow the ultrasonic transducer to be re-attached at the same location.
  • the alignment housing 514, and possibly the transducer array 501 may comprise one or more optical components such as lenses, fibers, and/or channels for optically coupling to an imaging system 515 that may be controlled by an imaging controller 516.
  • the imaging system may comprise a plurality of different imaging modalities such as an SLO imaging system an OCT imaging system, a video imaging system, etc. The different imaging modalities may be controlled in order to be co-aligned with each other.
  • the imaging systems may generate images using one or more light sources including both coherent light sources such as continuous wave lasers and/or pulsed lasers as well as non-coherent light sources.
  • the alignment housing, and/or the transducer array may have one or more controllable optical components in order to control the alignment of the imaging system 515 relative to the ultrasound transducer array. Additionally or alternatively, the transducer array may have one or more controllable components for controlling the alignment of the ultrasound transducer array relative to the optical imaging system 515.
  • FIG. 6 depicts a further ultrasound transducer device.
  • the transducer device may be used with an alignment housing and may be suitable for internal and/or external use.
  • the system comprises a 2D electronically steerable ultrasound array 601 arranged at the end of a flexible scope 602.
  • an optical fiber 603 In the core of the scope, there can be an optical fiber 603, which may terminate at an optical window or lens 604 that provides access to optical imaging.
  • the optical fiber may be controllably moveable, for example using actuators, within the scope in order to control the alignment of the optical imaging system with the ultrasound transducer.
  • the scope 602 may include one or more optical components such as lenses for adjusting the focus of the imaging system.
  • the transducer array 601 is connected to the system using wires 606, that are connected to the ultrasound transceivers.
  • the ultrasonic array may be positioned adjacent a treatment area using the optical imaging.
  • the optical imaging system may provide one or more imaging modalities that can be aligned with each other and may be used to identify the treatment location.
  • the ultrasound transducer array 601 may include a sensor (not depicted) in order to generate ultrasound image(s) of the treatment location.
  • the ultrasound image(s) may be aligned with the optical images by identifying the same features within the images.
  • the scope may also include one or more tubes, or channels (not shown in FIG. 6) arranged within the scope for an ultrasonic coupling medium and for providing suction which may be used to secure the device in a desired location.
  • the scope may act as the alignment housing described above or the scope may be connected to a separate alignment housing secured at or near the treatment location.
  • FIG. 7 depicts components of an imaging system incorporating an ultrasonic transducer device.
  • the system 700 is similar to that described in PCT application PCT/CA2022/050582, filed April 14, 2022 and incorporated herein by reference in its entirety.
  • the system 700 comprises a base device 702 that has input and output modules physically and optically coupled to it.
  • the base device 702 provides imaging functionality 704 with an imaging source 706 and imaging sensor 708.
  • the imaging functionality 704 may incorporate additional optics and/or components not depicted in FIG. 2.
  • the imaging source and sensor may vary depending upon the imaging functionality provided.
  • the imaging functionality may provide a digital ophthalmoscope using a white light source and a 2D image sensor, such as a CMOS sensor along with appropriate optics.
  • the imaging functionality may provide SLO (Scanning Laser Ophthalmoscopy) functionality that uses a laser source with scanning optics such as galvanometers for scanning the laser across the patient’s eye to generate an image of the eye.
  • SLO Scca
  • the base device 702 has an optical path 712 that provides an optical path between the imaging functionality 704 and a beam combiner/splitter device 714 that is optically coupled to one or more optical devices 716 such as focusing optics.
  • the focusing optics may comprise one or more adjustable lenses. Additionally or alternatively, the optical devices may comprise scanning optics for controlling a direction of the light on the patient’s eye.
  • the base device 702 comprises an optical output port 718 that allows the optical devices to be optically coupled to a corresponding optical coupler of an output optical module 720 that is mechanically coupled to the base device by a physical interface connector 722.
  • the physical connection may comprise cooperating features on both the base device and the output module 720.
  • the output module 720 is depicted as providing optics 724 that comprise moveable lenses 724a, 724b that can be used to adjust a focusing depth of the light source and imager through an output port 728 onto a patient’s eye 730. Additionally the output module 720 includes an ultrasonic transducer array 760 that is electronically steerable onto a particular location within the patient’s eye and arranged at an end of the output module 720. The optical imaging systems may be targeted at the same location as the ultrasound, or may be targeted at a different location. The output module 720 may be physically coupled to an alignment housing 762 that in turn is physically coupled to the patient’s eye. The alignment housing comprises one or more ports for adding or removing an acoustic coupling media between the transducer and the patient’s eye.
  • Combining one or more optical imaging modalities together along with an ultrasonic transducer that can be aligned with the optical imaging systems can be used to target specific locations which may be precisely identified with one or more of the optical imaging systems with ultrasound treatment.
  • the transducer may be provided with one or more ultrasound sensors that can be used to generate images from the ultrasound.
  • the combination of the imaging systems, or the light sources of one or more of the imaging systems, and the ultrasonic sensor may be used to provide photoacoustic imaging capabilities to the system.
  • the optical imaging systems and the ultrasound transducer and sensors may be used to generate images of the same features within the treatment location. By identifying the same physical features within the different images, it is possible to align the different imaging systems so that the same locations can be targeted using the different systems.
  • one or more lasers which may be provided as a light source of an imaging system or as a separate treatment laser, may be used for treatment either on its own or in combination with ultrasound.
  • the ophthalmological system 700 may comprise an input optical module 732 that is mechanically coupled to the base device 702 using a physical interface 734 between the module and the device.
  • the physical interface 734 may comprise cooperating features on each of the input module 732 and base device 702 that align a lock the input module in place relative to the base device.
  • the input module 732 provides a further light source 736 and corresponding imaging sensor 738 along with a beam combiner/splitter or other optical devices 740 for directing the light from the source to an optical interface 742 between the input module 732 and the base device 702 and from the optical interface 742 to the sensor 738.
  • the optical interface 742 couples the input module to a second optical path 744 of the base device 702 that in turn is optically coupled to the output module 720 through the beam combiner/splitter 714 and optical devices 716.
  • the input module may provide a different imaging modality from the imaging functionality 704 of the base device.
  • the base device may be provided with SLO imaging functionality while the input module 732 may provide OCT (Optical Coherence Tomography) imaging. It will be appreciated that not all of the imaging components for providing OCT imaging are depicted in FIG. 7.
  • the base device 702 may further include a controller 750 for controlling operation of the ophthalmological system 700.
  • the controller may control operating of the imaging functionality of the base device as well as providing a user interface for operating the system 700.
  • the user interface may be provided as a graphical user interface displayed on a display (not shown) of the base device or may comprise an interface provided on a remote device that may be in communication with the controller via a communication module such as a Wi Fi® radio, NIC (Network Interface Card), serial communication interfaces or other communication devices such as Bluetooth radios.
  • a communication module such as a Wi Fi® radio, NIC (Network Interface Card), serial communication interfaces or other communication devices such as Bluetooth radios.
  • the controller 750 may be provided as one or more individual control devices such as FPGAs (Field Programmable Gate Arrays), ASICs (Application Specific Integrated Circuits), and/or Central Processing Units (CPUs) that are operating together to provide the functionality of the system 700.
  • FPGAs Field Programmable Gate Arrays
  • ASICs Application Specific Integrated Circuits
  • CPUs Central Processing Units
  • the base device 702 described above provide internal imaging functionality as well as interfaces for coupling, both mechanically and optically, input and output modules to the base device.
  • an electrical interface 752 for the output module and an electrical interface 754 for the input module In addition to the physical and optical interfaces between the input/output modules and the base device, an electrical interface 752 for the output module and an electrical interface 754 for the input module.
  • the electrical interfaces 752, 754 provide one or more electrical connections between the modules and base device.
  • the electrical interfaces may couple the input/output modules to the controller 750 of the base device in order to provide electrical power to components of the input/output modules as well as provide an electrical communication path.
  • the input and output modules may each include one or more controllers 752, 754.
  • the controllers of the modules may communicate with the controller of the base device in order to co-ordinate operation of the modules. Additionally, the controllers of the input and output modules may provide information useful for configuring the modules with the base device. For example, the controller 752 of the output module may communicate identifying information stored in the module to the controller of the base device 702. The identifying information may provide information to the base device on how the base device can control the output module as well as other information such as possibly other requirements and/or limitations of the output module.
  • the controller of an output or input module may communicate identifying information about the module.
  • the identifying information may be provided in various ways such as using an RFID tag 756 on the module and an RFID tag reader 758 on the base device 702 that can communicate the module’s identifying information stored in the RFID tag.
  • the base device may also provide identifying information of the base device to the modules to allow the modules to identify the base device and possibly adjust the operation of the input or output module to operate with the base device.
  • the transducer array described above is depicted as having the transducer elements and the optical window arranged symmetrical about a longitudinal axis of the transducer. Flowever, it is possible for the optical elements and/or the transducer elements to be arranged in other configurations.
  • FIG. 8 depicts a method of performing a procedure using an ultrasonic device.
  • the method 800 includes affixing the alignment housing to the patient at the treatment location (802).
  • the alignment housing may have a surface that is designed to contact the patient at the treatment location.
  • the treatment location may be a patient’s eye and the alignment housing may have a surface similar to a contact lens that contacts the patient’s eye.
  • An ultrasonic transducer is coupled to the alignment housing (804).
  • the alignment housing and transducer have a corresponding shape and size that allow the transducer to be connected to the alignment housing.
  • the alignment housing and transducer may have one or more alignment features that allow the transducer to be connected to the alignment housing at a fixed or known position.
  • Acoustic coupling media may be added and or removed from the alignment housing through one or more ports of the alignment housing (806).
  • the acoustic coupling media improves the acoustic coupling between the transducer and the treatment location.
  • the ultrasonic treatment or procedure may be performed, such as performing an incision, ablation, or other tissue manipulation.
  • the transducer may first be coupled to the alignment housing which may then be affixed to the patient.
  • FIG. 9 depicts a method of performing a procedure using an imaging system and an ultrasonic device.
  • the method 900 may be performed by a system that includes both an ultrasonic imaging system comprising an ultrasound transducer and sensor as well as one or more imaging systems comprising a light source and sensor.
  • Ultrasound images are generated of the treatment location, or portion of the treatment location, (902) and optical images are generated of at least a partially overlapping portion of the treatment location (904).
  • the ultrasound and optical images are aligned with each other so that locations in one imaging systems can be mapped to corresponding locations in the other imaging systems.
  • the alignment may be performed by identifying features within the different images, identify corresponding features across the images of different modalities and determining the alignment between the systems based on locations of the corresponding features.
  • the co alignment of the different imaging systems may be done in software or may be done by physically adjusting relative positioning or focusing of the imaging systems relative to each other.
  • a target location for the procedure may be identified within the optical image(s), or possibly the ultrasound images, or a combination of the optical images and ultrasound images (908).
  • the procedure may be performed using the ultrasonic transducer (910).
  • the procedure may also be performed using one or more light sources of the imaging systems or separate treatment lasers.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

Un transducteur ultrasonore peut être disposé à l'intérieur d'un boîtier d'alignement qui peut être fixé à une surface d'un patient. Le boîtier d'alignement peut comprendre un ou plusieurs orifices qui permettent à un milieu de couplage acoustique d'être injecté dans un espace entre la surface sur laquelle est fixé le dispositif et le réseau de transducteurs.
PCT/CA2022/051038 2021-06-30 2022-06-29 Système, procédé et dispositifs de manipulation de tissu à l'aide d'un transducteur ultrasonore à orientation électronique WO2023272388A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3224096A CA3224096A1 (fr) 2021-06-30 2022-06-29 Systeme, procede et dispositifs de manipulation de tissu a l'aide d'un transducteur ultrasonore a orientation electronique

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163216637P 2021-06-30 2021-06-30
US63/216,637 2021-06-30
CAPCT/CA2022/050582 2022-04-14
PCT/CA2022/050582 WO2023197057A1 (fr) 2022-04-14 2022-04-14 Dispositifs d'imagerie biomédicale, systèmes et procédés d'utilisation

Publications (1)

Publication Number Publication Date
WO2023272388A1 true WO2023272388A1 (fr) 2023-01-05

Family

ID=84689747

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2022/051038 WO2023272388A1 (fr) 2021-06-30 2022-06-29 Système, procédé et dispositifs de manipulation de tissu à l'aide d'un transducteur ultrasonore à orientation électronique

Country Status (2)

Country Link
CA (1) CA3224096A1 (fr)
WO (1) WO2023272388A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2403603B1 (fr) * 2009-03-02 2014-07-16 Koninklijke Philips N.V. Sonde échographique transurétrale utilisable pour le traitement de la prostate
US20160022490A1 (en) * 2013-11-12 2016-01-28 Sabanci University Device and method for performing thermal keratoplasty using high intensity focused ultrasounds
CA2714116C (fr) * 2008-02-19 2017-01-03 Eye Tech Care Un dispositif servant au traitement de pathologie oculaire par l'application d'ultrason cible a haute intensite
US20180111008A1 (en) * 2015-03-31 2018-04-26 Eye Tech Care An eye probe for treatment with ultrasonic waves
US20190099291A1 (en) * 2016-03-18 2019-04-04 Aleyegn Technologies Llc Effective ocular lens positioning methods and apparatus
WO2021122762A1 (fr) * 2019-12-16 2021-06-24 Eye Tech Care Dispositif de traitement incluant un porte-outil et un outil incluant des moyens de deplacement en rotation sans contact

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2714116C (fr) * 2008-02-19 2017-01-03 Eye Tech Care Un dispositif servant au traitement de pathologie oculaire par l'application d'ultrason cible a haute intensite
EP2403603B1 (fr) * 2009-03-02 2014-07-16 Koninklijke Philips N.V. Sonde échographique transurétrale utilisable pour le traitement de la prostate
US20160022490A1 (en) * 2013-11-12 2016-01-28 Sabanci University Device and method for performing thermal keratoplasty using high intensity focused ultrasounds
US20180111008A1 (en) * 2015-03-31 2018-04-26 Eye Tech Care An eye probe for treatment with ultrasonic waves
US20190099291A1 (en) * 2016-03-18 2019-04-04 Aleyegn Technologies Llc Effective ocular lens positioning methods and apparatus
WO2021122762A1 (fr) * 2019-12-16 2021-06-24 Eye Tech Care Dispositif de traitement incluant un porte-outil et un outil incluant des moyens de deplacement en rotation sans contact

Also Published As

Publication number Publication date
CA3224096A1 (fr) 2023-01-05

Similar Documents

Publication Publication Date Title
AU2004311458B2 (en) Component ultrasound transducer
US9345910B2 (en) Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
CN109416907B (zh) 超声成像和治疗设备
US8801615B2 (en) System and method for ultrasound therapy treatment
US20030009155A1 (en) Method for accurate optical treatment of an eye's fundus
US20060079816A1 (en) Method and system for treating stretch marks
US20060074314A1 (en) Method and system for noninvasive mastopexy
TW201904522A (zh) 可操縱的高強度聚焦的超音波元件
JP2005500108A (ja) 生物学的組織の熱的切除のための装置と方法
CA3073552A1 (fr) Ensemble transducteur pour generer des ultrasons focalises
EP2916783A1 (fr) Dispositif et procédé permettant d'effectuer une kératoplastie thermique au moyen d'ultrasons focalisés de haute énergie
JP2011526808A (ja) Ｈｉｆｕトランスデューサを用いる複合撮像と擬似３ｄ撮像の使用法
CN107530046B (zh) 漫射声学共焦成像器
CN107106871A (zh) 用于投射聚焦超声的手持设备以及相关方法
KR101259381B1 (ko) 고강도 집속 초음파용 어플리케이터
WO2023272388A1 (fr) Système, procédé et dispositifs de manipulation de tissu à l'aide d'un transducteur ultrasonore à orientation électronique
JP2008535564A (ja) 超音波医療装置並びに関連する使用方法
CA2681944A1 (fr) Traitement spinal et appareil associe
US20020151940A1 (en) Transcutaneous spine trauma and disorders treatment using ultrasonically induced confined heat (ulich) zone
Fleury et al. High intensity therapeutic ultrasound transducer performance and characterisation
KR102369321B1 (ko) 영상 및 치료 융합형 변환기 및 이를 포함하는 초음파 시스템
JP2019509868A (ja) 生理学的脈管内の流体流を制限するデバイス及びシステム
US20140276053A1 (en) Multi-element therapy and imaging transducer for ultrasound therapy
Yasui et al. Focused ultrasonic device for sonodynamic therapy in the human body
WO2024103159A1 (fr) Systèmes à ultrasons focalisés à guidage par imagerie échographique et procédés associés

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22831102

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 3224096

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE